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Abstract
Feline morbillivirus infections have gained increased attention due to repeated reports of their association with urinary tract 
disease in cats. In the present study, 112 serum samples from free-roaming domestic cats in Chile were tested for antibodies 
against feline morbillivirus genotypes 1 and 2 (FeMV-1 and FeMV-2) using an indirect immunofluorescence assay. In total, 
63% of the animals showed antibodies against one or both FeMV genotypes. Antibodies directed exclusively against FeMV-2 
were significantly more prevalent in male cats. The correlation of sex and FeMV-2 infection might give insight into potential 
routes of transmission. We provide, for the first time, serological data on FeMV in Chile.
The family Paramyxoviridae currently comprises 78 virus 
species divided into four subfamilies and 17 genera cover-
ing a broad host range including mammals, birds, fish and 
reptiles [1]. In 2012, a new paramyxovirus was detected in 
stray cats from Hong Kong, designated as feline morbilli-
virus (FeMV, formally known as FmoPV) [2]. Subsequent 
studies verified FeMV to be present in Japan [3], Germany 
[4], Italy [5], the USA [6], Brazil [7], Turkey [8], the UK [9], 
Malaysia [10] and mainland China [11]. In-depth analysis 
of complete genome sequences revealed viral diversity of 
FeMV strains from different locations [3, 12, 13]. In 2019, 
a large surveillance program in Germany identified a sec-
ond genotype of FeMV (FeMV-2) with 78% whole-genome 
nucleotide sequence identity to the previously detected 
FeMV isolates [14]. In infected cats, viral proteins were 
predominantly detected in the kidney but were also found 
in other organs (e.g., lymph nodes) [2, 12, 13, 15]. FeMV 
involvement in chronic kidney diseases (CKD) has been sug-
gested. CKD is common in domestic cats, with a reported 
incidence of 28-50%, primarily affecting older animals [16, 
17]. Prevalence data for FeMV obtained by detection of anti-
bodies against the viral nucleoprotein (N) in Japan, Hong 
Kong and the UK revealed that 21.0, 27.8 and 30% of the 
animals, respectively, were FeMV positive, [2, 9, 12]. Simi-
lar results were obtained using a phosphoprotein (P)-based 
enzyme-linked immunosorbent assay (ELISA) [18]. In the 
USA and Brazil, FeMV has been detected by RT-PCR [6, 
7], but so far, no serological studies have been published.
We analyzed serum samples from 112 domestic cats. The 
cohort comprised 62 female and 50 male, rural, free-roam-
ing, mix-bred, short-haired cats, with an average age of 30 
Handling Editor: Bert K. Rima.
Electronic supplementary material The online version of this 
article (https ://doi.org/10.1007/s0070 5-020-04882 -2) contains 
supplementary material, which is available to authorized users.
 * Constanza Napolitano 
 constanza.napolitano@ulagos.cl
 * Michael Sieg 
 michael.sieg@vetmed.uni-leipzig.de
1 Institute of Virology, Faculty of Veterinary Medicine, 
Leipzig University, An den Tierkliniken 29, 04103 Leipzig, 
Germany
2 PhD Program in Conservation Medicine, Facultad de 
Ciencias de la Vida, Universidad Andres Bello, República 
252, Santiago, Chile
3 Facultad de Ciencias de la Vida, Universidad Andres Bello, 
República 252, Santiago, Chile
4 Instituto Agroalimentario de Aragón-IA2 (Universidad de 
Zaragoza-CITA), Miguel Servet 177, 50013 Zaragoza, Spain
5 Fundación ARAID, Avda. de Ranillas, 50018 Zaragoza, 
Spain
6 Departamento de Ciencias Biológicas y Biodiversidad, 
Universidad de Los Lagos, Av. Fuchslocher 1305, Osorno, 
Chile
7 Instituto de Ecología y Biodiversidad (IEB), Santiago, Chile
 J. Busch et al.
1 3
± 4.2 months. Over 90% of the cats were less than 4 years of 
age. None of the animals had been neutered, vaccinated or 
dewormed. The sampling area comprised nine regions from 
central to southern Chile. In the present study, we deter-
mined the antibody status against FeMV-1 and FeMV-2 
using an immunofluorescence assay (IFA) developed for 
both genotypes. Viruses were isolated from urine sam-
ples taken from two persistently infected cats in Germany. 
Propagation in cell culture was performed as described 
previously for FeMV-1 [19] and for FeMV-2 [14]. Whole 
genome sequences are available under GenBank accession 
no. MG563820 and MK182089, respectively. In brief, CrFK 
cells were infected with FeMV-1 (MOI = 0.01), and LLC-
MK2 cells were infected with FeMV-2 (MOI = 0.01). After 
five days, cells were fixed with 80% acetone, blocked with 
5% (w/v) BSA in PBS before cat sera were applied at a dilu-
tion of 1/100 (v/v) in 1% (w/v) BSA in PBS overnight at 
4°C. After washing with PBS, a goat anti-cat IgG (H+L) 
Alexa Fluor 488–conjugated antibody (Dianova, Germany), 
diluted 1/500 (v/v) in 1% (w/v) BSA in PBS was applied for 
30 min at 37°C. Prior to evaluation of the signal, cells were 
washed twice with PBS. Uninfected cells served as nega-
tive controls for each sample and allowed determination of 
virus-specific signals. Graphs as well as figures were gener-
ated using MS Office, and statistics were performed using 
the GraphPad QuickCalcs website to determine significance 
by two-tailed Fisher’s exact test [20]. RT-PCR for the detec-
tion and further phylogenetic analysis of feline morbillivi-
ruses was not possible due to the limited amount of serum 
available.
The IFA approach was evaluated using sera from the 
same persistently infected cats whose urine had been used 
to propagate the respective FeMV genotype, as well as spe-
cific antibodies against the FeMV N or P protein (shown in 
the supplementary file). Based on the observed fluorescence 
signals, cat sera were judged to be positive for FeMV-1 only, 
FeMV-2 only, positive for both genotypes (FeMV double 
positive) or FeMV negative. Representative results are 
shown in Figure 1, which shows viral intracytoplasmic inclu-
sion bodies indicated by arrows. We found that 63% of the 
cats (71 animals) had antibodies against FeMV. Thirty per-
cent of these samples were seropositive for both genotypes. 
It is currently unknown whether double-positive sera are the 
result of coinfections or consecutive infections, or possibly 
due to cross-reactive antibodies derived from either FeMV-1 
or FeMV-2 monoinfection. Furthermore, 24% and 9% of 
Fig. 1  Representative images of IFA against both FeMV genotypes. 
Serum A was found to be positive for FeMV-1 only, serum B was 
positive for FeMV-2 only, serum C was positive for both types, and 
serum D was negative for both types. Arrows indicate virus-specific 
signals. Scale bars indicate 20 μm.
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the animals were positive FeMV-1 only and FeMV-2 only, 
respectively (Fig. 2). In combination with the staining pat-
tern observed in Supplementary Figure 1, these data suggest 
that sera that are positive against only one genotype might 
be restricted in their response to either one viral protein or 
even a specific epitope. In addition, sex-related differences 
in seroprevalence of FeMV were investigated. As depicted 
in Figure 3, only slight differences between female (69%) 
and male (74%) cats were observed in the overall FeMV 
seroprevalence. However, statistically significant differences 
were detected between the sexes for the seroprevalence of 
FeMV-2 only (p = 0.0407). While 16% of male cats had 
antibodies against FeMV-2 only, just 3% of the female cats 
were seropositive for FeMV-2 only. Such a correlation was 
not observed for FeMV-1.
Overall, our results are in accordance with previous 
studies using recombinant viral N protein in immunoblot 
assays [2, 9], N-protein-expressing cells [12], or recombi-
nant-P-protein-based ELISA [18]. Our experimental set-
ting allowed the detection of antibodies against all viral 
structural proteins simultaneously. This advantage might 
explain the higher seroprevalence detected in Chilean cats 
compared with studies from other countries. For instance, 
experiments conducted in Hong Kong, Japan, and the UK [2, 
9, 12], used single-protein-based assays and thus might be 
unable to detect antibody responses to other viral proteins, 
e.g., the viral surface proteins. This is supported by a study 
using whole-virus immunoblot analysis [3], which con-
firmed differences in antibody reactivity against structural 
FeMV proteins. The FeMV-specific antibody prevalence in 
Japanese cats was found to be 22%. Differences compared 
to our data (24% FeMV-1 only and additionally 30% FeMV 
double positive) might be due to the limited sample size 
(n = 13) in the previous study or country-specific differ-
ences in the epidemiological situation. Samples included 
in the study by Sakaguchi et al. published in 2014 were 
obtained from cats brought to a veterinary clinic for various 
reasons. Those cats are thus likely to have had an owner. 
In comparison, the cats in Chile analyzed in this study had 
an owner but were not confined and were in a rural set-
ting (with the exception of one animal), and the likelihood 
of infection with FeMV might therefore have been higher. 
Another aspect that may explain the higher FeMV seroprev-
alence in Chile than in other countries might be the different 
global distribution of the two FeMV genotypes, since no 
serological data were obtained on the American continents, 
although FeMV RNA has been detected in the USA [6] and 
Brazil [7]. A complete genome sequence was available for 
the US strain, only. An amino acid sequence comparison 
between the FeMV-1 strain used in this study and the US 
Fig. 2  Seroprevalence of FeMV antibodies determined in samples 
from free-roaming domestic cats in Chile. Sera were tested separately 
for antibodies against each genotype
Fig. 3  Comparison of seroprev-
alence rates of FeMV antibodies 
in samples taken from male and 
female cats in Chile. Statistical 
significance is shown as the 
p-value
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strain (accession no. KR014147) revealed 97.11% sequence 
identity in the N protein, 86.73% in the P protein, 96.14% 
in the M protein, 94.29% in the F protein, 94.79% in the H 
protein, and 96.05% in the RNA polymerase protein. These 
data point towards a limited variability of FeMV-1 glob-
ally, and cross-reactivity of the antibodies generated can be 
assumed. A high degree of similarity among all available 
FeMV-1 strains was also shown previously [21]. The overall 
amino acid sequence identity in the N, P, M, F, H and RNA 
polymerase protein between FeMV-1 and FeMV-2 used in 
this study was found to be 90.94%, 77.19%, 91.39%, 89.50%, 
86.53%, and 90.64%, respectively. Therefore, assays based 
solely on FeMV-1 sequences or proteins might underesti-
mate the prevalence of FeMV-2. Using our IFA approach, we 
detected a significantly higher seroprevalence of FeMV-2 in 
male cats. This might be explained by the lack of neutering 
in this cohort, resulting in closer and more frequent social 
contacts between animals, increased roaming distance, urine 
spraying, and sexual activity [22, 23]. Like for FeMV-2, the 
seroprevalence of feline immunodeficiency virus (FIV) and 
feline leukemia virus (FeLV)’ as well as ’canine distemper 
virus (CDV) have also been reported to be higher in male 
cats [24]. Since no such correlation was detected for FeMV-
1, an alternative route of transmission may be considered.
Correlations with FeLV, FIV and ??canine distemper 
virus?? (CDV) data evaluated based on the samples of this 
investigation in the course of a previous study [25] showed 
that two cats that were double positive for FeMV-1 and 
FeMV-2 were also positive for FIV antibodies. All but one 
of the animals were negative for CDV antibodies [25]. Out 
of ten animals that were positive for FeLV antigen, two were 
positive for FeMV-1 only, two positive for were FeMV-2 
only, and two were positive for both FeMV-1 and FeMV-2. 
Furthermore, four FeLV-antigen-positive cats were FeMV 
negative. Due to the limited sample size, the statistical corre-
lation between FIV, CDV and FeLV status of cats in compar-
ison to FeMV antibodies could not be determined. It is, how-
ever, important to note that FeMV results obtained using the 
IFA used in the present study are not attributable to cross-
reactivity against either of those feline viruses, especially as 
might be expected in the case of CDV. The serum samples 
that were analyzed were collected between 2008 and 2010 
and between 2015 and 2016. No differences regarding the 
seroprevalence of FeMV antibodies were detected between 
these two periods. It can be concluded that the virus was 
circulating as early as 2008 in Chile, which is similar to what 
was reported by Woo et al. in Hong Kong [2].
In conclusion, our findings demonstrate a high seropreva-
lence of FeMV in Chilean free-roaming cats. Our IFA data 
indicate that FeMV seroprevalence data might be higher 
than reported in previous serological surveys based solely 
on the antibody response against a single viral protein. The 
susceptibility of female and male animals to both FeMV 
genotypes should be investigated further, as our data suggest 
possible sex-specific effects regarding the seroprevalence of 
different FeMV genotypes.
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